Evan J. Anderson
0000-0002-1576-4420
Publication & Citation Trends
Publications
457 total
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants OA
Cited by 25
Semantic Scholar
Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial. OA
Cited by 17
Semantic Scholar
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial OA
Cited by 39
Semantic Scholar
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial OA
Cited by 2
Semantic Scholar
Plain Language Summary of a Clinical Trial Evaluating mRNA-1273, Moderna's mRNA-Based COVID-19 Vaccine, in Children 6 Through 11 Years of Age OA
Cited by 2
Semantic Scholar
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine – An Interim Analysis OA
Cited by 2
Semantic Scholar
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age OA
Cited by 120
Semantic Scholar
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 PDF
Cited by 751
OpenAlex
Research Topics
Respiratory viral infections research
(155)
SARS-CoV-2 and COVID-19 Research
(108)
Influenza Virus Research Studies
(97)
COVID-19 Clinical Research Studies
(92)
Pneumonia and Respiratory Infections
(78)
Affiliations
Northwestern University
University of Maryland, Baltimore
Brigham and Women's Hospital
Rutherford Appleton Laboratory
Oklahoma State Department of Health